TREATMENT OF ALZHEIMER'S DISEASE: Rationale and Strategies

This publication has 99 references indexed in Scilit:

• Metrifonate: A Cholinesterase Inhibitor for Alzheimer's Disease Therapy
  CNS Drug Reviews, 2006
• Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography study
  Neuropsychology Review, 1996
• AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells
  Neuroscience Letters, 1995
• Complements, microglial cells and amyloid fibril formation
  Research in Immunology, 1992
• Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
  FEBS Letters, 1991
• Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?
  Immunology Today, 1991
• Complement activation in amyloid plaques in Alzheimer’s dementia
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1988
• Morphological response of axotomized septal neurons to nerve growth factor
  Journal of Comparative Neurology, 1988
• The prevalence of dementia: A quantitative integration of the literature
  Acta Psychiatrica Scandinavica, 1987
• Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
  New England Journal of Medicine, 1986